Treatment of fibrotic interstitial lung disease: current approaches and future directions.
Lancet
; 398(10309): 1450-1460, 2021 10 16.
Article
em En
| MEDLINE
| ID: mdl-34499866
ABSTRACT
Fibrotic interstitial lung disease (ILD) represents a large group of pulmonary disorders that are often progressive and associated with high morbidity and early mortality. Important advancements in the past 10 years have enabled a better understanding, characterisation, and treatment of these diseases. This Series paper summarises the current approach to treatment of fibrotic ILDs, both pharmacological and non-pharmacological, including recent discoveries and practice-changing clinical trials. We further outline controversies and challenges, with discussion of evolving concepts and future research directions.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fibrose Pulmonar
/
Doenças Pulmonares Intersticiais
Limite:
Humans
Idioma:
En
Revista:
Lancet
Ano de publicação:
2021
Tipo de documento:
Article